8 Coupons
-
Special Offer
-
30% off
why novartis� landmark cancer drug approval is great news for bluebird . .
andrew kaye, head of policy at macmillan cancer support said it was �shocking� that a cancer patient had to wait 541 days for treatment. .
despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6.
. promoted content
.